<?xml version="1.0" encoding="UTF-8"?>
<p>Preclinical evidence. 
 <italic>Silybum marianum</italic> has not been experimentally proven for symptoms of respiratory disease. Silybin, the main flavonolignan from the seed of 
 <italic>S. marianum</italic>, has demonstrated an anti-inflammatory activity by inhibiting the spontaneous and LPS-stimulated NF-kB activation as well as the production of inflammatory cytokines (
 <xref rid="B98" ref-type="bibr">Corchete, 2008</xref>; 
 <xref rid="B210" ref-type="bibr">Giorgi et al., 2012</xref>).
</p>
